Methods for Compounding and Delivering a Therapeutic Agent to the Adventitia of a Vessel

• US 20090204104A1
• Filed: 05/04/2005
• Published: 08/13/2009
• Est. Priority Date: 05/13/2004
• Status: Abandoned Application

• Current Assignee: Medtronic Vascular, Inc. (Medtronic Plc)
• Original Assignee: Medtronic Vascular, Inc. (Medtronic Plc)
• Inventors: Patel, Kaushik A., Judd, Dianne, Tremble, Patrice, Udipi, Kishore, Cheng, Peiwen, Sundar, Rangarajan, Tedeschi, Eugene
• Application Number:
  US11/568,779
• Publication Number:
  US 20090204104A1
• Time in Patent Office: Days
• US Class Current: 604/509
• CPC Class Codes: A61K 9/16 Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction A61K9/20 takes precedence if the final form is a tablet; microspheres with drug-free outer coating, microcapsules A61K9/50; mixture of different granules, microcapsules, (coated) microparticles A61K9/5084; nanoparticles A61K9/51
• CPC Class Codes: A61M 25/0084 being one or more injection needles
• CPC Class Codes: A61P 9/02 Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Abstract

The invention provides a method of delivering a therapeutic agent to the adventitia of a vessel using a catheter-based microsyringe. A therapeutic agent is formed into microparticles, which are dispersed throughout an appropriate liquid carrier to form a therapeutic mixture. A catheter is provided that includes a microsyringe operably attached to an actuator. The microsyringe includes a hollow needle in fluid communication with a therapeutic agent delivery conduit. The catheter is introduced into a target area of a vessel. The actuator is operated to thrust the needle into a wall of the vessel. The therapeutic mixture is supplied to the therapeutic agent delivery conduit and delivered through the conduit to the needle and thereby into the adventitia of the vessel. The actuator is again operated to withdraw the needle from the wall of the vessel and to enclose it within the actuator. The catheter is then removed from the vessel.

Claims

1. A method of delivering a therapeutic agent to the adventitia of a vessel using a catheter-based microsyringe, comprising:

forming a therapeutic agent into a plurality of microparticles;

dispersing the microparticles throughout a pharmaceutically acceptable liquid carrier to form a therapeutic mixture;

providing a catheter, the catheter including a microsyringe operably attached to an actuator, the microsyringe including a hollow needle in fluid communication with a therapeutic agent delivery conduit, wherein the actuator is operable between an unactuated condition in which the needle is enclosed within the actuator and an actuated condition in which the needle is thrust outward by the actuator;

introducing the catheter into a target area of a vessel;

operating the actuator such that the needle is thrust outward and into a wall of the vessel;

supplying the therapeutic mixture to the therapeutic agent delivery conduit;

delivering the therapeutic mixture through the therapeutic agent delivery conduit to the needle and through the needle into an adventitia of the vessel;

operating the actuator such that the needle is withdrawn from the wall of the vessel and enclosed within the actuator; and

removing the catheter from the vessel.

2. The method of claim 1 wherein the actuator comprises an inflatable balloon.

3. The method of claim 2 wherein operating the actuator such that the needle is thrust outwardly and into a wall of the vessel comprises inflating the balloon.

4. The method of claim 2 wherein operating the actuator such that the needle is withdrawn from the vessel and enclosed within the actuator comprises deflating the balloon.

5. The method of claim 1 wherein forming the therapeutic agent into a plurality of microparticles comprises combining the therapeutic agent with a plurality of microspheres.

6. The method of claim 5 wherein combining the therapeutic agent with a plurality of microspheres comprises encapsulating the therapeutic agent within a plurality of microspheres.

7. The method of claim 5 wherein combining the therapeutic agent with a plurality of microspheres comprises attaching the therapeutic agent to an outer surface of a plurality of microspheres.

8. The method of claim 5 wherein the microspheres comprise one of a biodegradable matrix material and a biocompatible matrix material.

9. The method of claim 8 wherein the matrix material is selected from a group consisting of a biodegradable polymer, a biocompatible polymer, a protein, a polysaccharide, and a lipid.

10. The method of claim 1 wherein forming the therapeutic agent into a plurality of microparticles comprises forming the therapeutic agent into a plurality of dendrimers.

11. The method of claim 1 wherein forming the therapeutic agent into a plurality of microparticles comprises positioning the therapeutic agent as guest molecules within a plurality of dendritic voids formed in a plurality of dendrimers.

12. The method of claim 1 wherein forming the therapeutic agent into a plurality of microparticles comprises forming the therapeutic agent into globules that comprise a discontinuous phase of an emulsion.

13. The method of claim 12 wherein dispersing the microparticles throughout a pharmaceutically acceptable liquid carrier comprises mixing the therapeutic agent with a biocompatible dispersion medium to form an emulsion.

14. The method of claim 13 wherein a portion of the therapeutic agent delivery conduit or the needle is tortuous, and wherein the emulsion is mixed by the resulting turbulence prior to delivery.

15. The method of claim 13 wherein a portion of the therapeutic agent delivery conduit includes at least two channels that empty into a single lumen within the delivery conduit, and wherein the emulsion is mixed by the resulting turbulence prior to delivery.

16. The method of claim 1 wherein forming the therapeutic agent into a plurality of microparticles permits a timed release of the therapeutic agent.

17. The method of claim 1 further comprising:

prior to removing the catheter from the vessel, repositioning the catheter;

operating the actuator such that the needle is thrust outward and into a wall of the vessel;

supplying the therapeutic mixture to the therapeutic agent delivery conduit;

delivering the therapeutic mixture through the therapeutic agent delivery conduit to the needle and through the needle into an adventitia of the vessel; and

operating the actuator such that the needle is withdrawn from the wall of the vessel and enclosed within the actuator.

18. A method of compounding a therapeutic agent for delivery to the adventitia of a vessel using a catheter-based microsyringe, comprising:

forming a therapeutic agent into a plurality of microparticles; and

dispersing the microparticles throughout a liquid carrier suitable for delivery to an adventitia of a vessel.

19. The method of claim 18 wherein forming the therapeutic agent into a plurality of microparticles comprises combining the therapeutic agent with a plurality of microspheres.

20. The method of claim 19 wherein combining the therapeutic agent with a plurality of microspheres comprises encapsulating the therapeutic agent within a plurality of microspheres.

21. The method of claim 19 wherein combining the therapeutic agent with a plurality of microspheres comprises attaching the therapeutic agent to an outer surface of a plurality of microspheres.

22. The method of claim 19 wherein the microspheres comprise one of a biodegradable matrix material and a biocompatible matrix material.

23. The method of claim 22 wherein the matrix material is selected from a group consisting of a biodegradable polymer, a biocompatible polymer, a protein, a polysaccharide, and a lipid.

24. The method of claim 18 wherein forming the therapeutic agent into a plurality of microparticles comprises forming the therapeutic agent into a plurality of dendrimers.

25. The method of claim 18 wherein forming the therapeutic agent into a plurality of microparticles comprises positioning the therapeutic agent as guest molecules within a plurality of dendritic voids formed in a plurality of dendrimers.

26. The method of claim 18 wherein forming the therapeutic agent into a plurality of microparticles comprises forming the therapeutic agent into globules that comprise a discontinuous phase of an emulsion.

27. The method of claim 26 wherein dispersing the microparticles throughout a liquid carrier comprises mixing the therapeutic agent with a biocompatible dispersion medium to form an emulsion.

28. The method of claim 18 wherein forming the therapeutic agent into a plurality of microparticles permits a timed release of the therapeutic agent.